In February 2019 the FDA announced that it has received a total of 660 medical device reports (MDRs) regarding breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), cases in the United States since 2010. This new total indicates an increase of about 246 new reports of breast implants … More
Main Navigation Menu
➤ Pharmaceutical Drug Injury Lawsuits
➤ Asbestos and Mesothelioma Claims
➤ Benzene Diseases and Cancers Claims
➤ GenX Water Contamination Cancer Cases
➤ Breast Implants Lymphoma Cancer Cases
➤ Free Case Evaluation by Lawyer Tom Lamb
➤ About the Law Offices of Thomas J. Lamb
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Collection of Articles by Our Law Firm
Please know that you can use our Quick Contact Form to tell us a bit about your case.
Recent Articles
Pleural mesothelioma: tackling a deadly cancer
A new study from the University of Pittsburgh has highlighted six factors that are associated with improved survival in patients with mesothelioma; age under 45 years, female, epithelioid histological subtype, peritoneal mesothelioma, stage 1 cancer, and being treated with both surgery and … More
Diabetes Drugs In DPP-4 Inhibitor Class Significantly Increase Risk Of Crohn’s Disease (CD)
The medical journal Annals of Pharmacotherapy has published an article, “Dipeptidyl Peptidase-4 Inhibitors and Inflammatory Bowel Disease Risk: A Meta-analysis”, which concludes that dipeptidyl peptidase-4 (DPP-4) inhibitors increase the risk of Crohn’s disease (CD). It goes on to point out that … More
Talc-asbestos lawsuits to stay in Pa. courts because of corporate registration law
According to the ruling of a federal judge, Pennsylvania courts now have jurisdiction over [ talc-asbestos lawsuits ] because the defendant followed state law in registering to do business in the state. On Wednesday, U.S. District Court for the Eastern District of Pennsylvania Judge Michael M. … More
Uloric Recall Discussed By FDA Advisory Committees In January 2019
On January 10, 2019 the Arthritis Advisory Committee and the Drug Safety and Risk Management Advisory Committee panelists discussed the potential biological mechanisms behind cardiovascular (CV) events associated with Uloric (febuxostat) use. From this January 11, 2019 MedPage Today report, “Make … More
Four J&J Talc Cases Moving to Trial in New York’s Oft-Maligned Asbestos Court
Four talcum powder suits against Johnson & Johnson are set to proceed this month to trial in the New York City Asbestos Litigation court, where plaintiffs attorneys may be able to wield a formidable weapon in the threat of punitive damages, a remedy that had been unavailable for more than two … More